+3.90%
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).
The AIM ImmunoTech Inc. (AIM) stock price today is $0.57, reflecting a +3.90% move since the market opened. The company’s market capitalization stands at $2.41M, with a daily trading volume of $75.50K shares. For investors tracking price trends, AIM ImmunoTech Inc. stock has ranged between $0.54 and $0.58 today. The previous closing price was $0.55.
Ready to get started? Follow the steps below, or read our guide on how to buy AIM ImmunoTech stock on Kraken starting from $10.
Create an account
Open the Kraken app to confirm your eligibility and follow the steps for account verification.
Deposit funds
Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.
Buy AIM
Search for AIM in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy AIM.
Explore the most-traded stocks today
LNKS
SKYQ
COCP
Browse today’s biggest stock market winners
Compare the worst-performing stocks of the day
Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.
*Other applicable fees may apply.
